发明授权
- 专利标题： Glucocorticoid-selective anti-inflammatory agents
- 专利标题（中）： 糖皮质激素选择性抗炎药
-
申请号： US10201524申请日： 2002-07-23
-
公开(公告)号： US06951942B2公开(公告)日： 2005-10-04
- 发明人: Michael J. Coghlan , James P. Edwards , Steven W. Elmore , Todd K. Jones , Michael E. Kort , Philip R. Kym , Jimmie L. Moore , John K. Pratt , Alan X. Wang
- 申请人： Michael J. Coghlan , James P. Edwards , Steven W. Elmore , Todd K. Jones , Michael E. Kort , Philip R. Kym , Jimmie L. Moore , John K. Pratt , Alan X. Wang
- 申请人地址： US IL Abbott Park US CA San Diego
- 专利权人： Abbott Laboratories,Ligand Pharmaceuticals Incorporated
- 当前专利权人： Abbott Laboratories,Ligand Pharmaceuticals Incorporated
- 当前专利权人地址： US IL Abbott Park US CA San Diego
- 代理机构： Pillsbury Winthrop LLP
- 主分类号： C07D491/052
- IPC分类号： C07D491/052 ; A61K31/4741 ; A61K31/519 ; A61K31/5377 ; A61P29/00 ; A61P37/00 ; A61P43/00 ; C07D491/04 ; C07D491/02 ; C07D491/06
摘要：
Compounds having Formula I are useful for partially or fully antagonizing, repressing, agonizing, or modulating the glucocorticoid receptor and treating immune, autoimmune and inflammatory diseases in a mammal. Also disclosed are pharmaceutical compositions comprising compounds of Formula I and methods of inhibiting immune or autoimmune diseases in a mammal.
公开/授权文献
- US20030073703A1 Glucocortiocoid-selective antinflammatory agents 公开/授权日：2003-04-17